Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

IREN – IREN Ltd

IREN — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

17.28

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

0.23

EPS Last/This Y

-0.34

EPS This/Next Y

-0.46

Price

35.1

Target Price

81.23

Analyst Recom

1.71

Performance Q

-16.41

Upside

-13.2%

Beta

4.24

Ticker: IREN




14 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09IREN38.780.760.631958091
2026-03-10IREN38.080.750.702044077
2026-03-11IREN41.920.750.402091696
2026-03-12IREN41.430.760.882128829
2026-03-13IREN41.370.760.872128829
2026-03-17IREN43.040.730.922037871
2026-03-18IREN42.210.740.482065960
2026-03-19IREN41.590.740.662088576
2026-03-20IREN41.190.751.102137961
2026-03-23IREN42.150.780.351489171
2026-03-24IREN41.10.740.731579326
2026-03-25IREN41.420.750.481616038
2026-03-26IREN37.530.750.681647430
2026-03-27IREN35.40.760.781719367
DateSymbolLatestP/C OIP/C VolTotal OI
14 items Current Page1 of 1




14 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09IREN38.87- -499.40.39
2026-03-10IREN38.12-341.0-494.5-0.01
2026-03-11IREN41.97-341.0-502.1-0.01
2026-03-12IREN41.65-341.0-495.20.07
2026-03-13IREN41.57-341.0-496.00.07
2026-03-17IREN42.97-341.0-492.90.07
2026-03-18IREN42.23-341.0-494.60.07
2026-03-19IREN41.51-341.0-494.60.07
2026-03-20IREN41.34-341.0-495.20.07
2026-03-23IREN42.01-341.0-496.80.07
2026-03-24IREN41.12-341.0-494.10.07
2026-03-25IREN41.42-341.0-496.20.07
2026-03-26IREN37.46-341.0-489.60.07
2026-03-27IREN35.10-341.0-491.70.07
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
14 items Current Page1 of 1




14 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09IREN-5.723.4014.04
2026-03-10IREN-5.723.4014.04
2026-03-11IREN-5.723.4014.88
2026-03-12IREN0.003.4014.88
2026-03-13IREN0.003.4014.88
2026-03-17IREN0.003.4314.88
2026-03-18IREN0.003.4314.88
2026-03-19IREN0.003.4314.88
2026-03-20IREN0.003.4314.88
2026-03-23IREN0.003.4414.88
2026-03-24IREN0.003.4414.88
2026-03-25IREN0.003.4417.28
2026-03-26IREN0.003.4417.28
2026-03-27IREN0.003.4417.28
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
14 items Current Page1 of 1

Last Quarter Act. EPS

-0.44

Avg. EPS Est. Current Quarter

-0.26

Avg. EPS Est. Next Quarter

-0.21

Insider Transactions

Institutional Transactions

3.44

Beta

4.24

Average Sales Estimate Current Quarter

219

Average Sales Estimate Next Quarter

315

Fair Value

Quality Score

85

Growth Score

91

Sentiment Score

5

Actual DrawDown %

54.3

Max Drawdown 5-Year %

Target Price

81.23

P/E

40.2

Forward P/E

47.25

PEG

0.62

P/S

23.89

P/B

6.95

P/Free Cash Flow

EPS

0.87

Average EPS Est. Cur. Y​

0.07

EPS Next Y. (Est.)

-0.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

57.08

Relative Volume

0.73

Return on Equity vs Sector %

4

Return on Equity vs Industry %

1.5

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-491.7
IREN Financial
$35.09
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
13/25
Volume
6/15
Valuation
15/20
TP/AR
3/10
Options
3/10
RSI
37.2
Range 1M
2.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
44 /100
WEAK
Momentum
8/25
Growth
18/30
Estimates
8/20
Inst/Vol
5/15
Options
5/10
EPS Yr
42.5%
EPS NY
37.2%
52W%
41.4%
💎
Long-Term Value
Quality companies, undervalued
53 /100
WEAK
🟢 BUY +131.5% upside
Quality
14/30
Valuation
16/30
Growth
16/25
Stability
4/10
LT Trend
3/5
Upside
+131.5%
Quality
85
IREN LIMITED
Sector: Financial Services
Industry: Capital Markets
Employees: 257
IREN Limited operates in the vertically integrated data center business in Australia and Canada. The company owns and operates computing hardware, as well as electrical infrastructure and data centers. It also mines Bitcoin, a scarce digital asset that is created and transmitted through the operation of a peer-to-peer network of computers running the Bitcoin software. The company was formerly known as Iris Energy Limited and changed its name to IREN Limited in November 2024. The company was incorporated in 2018 and is based in Sydney, Australia.
IREN

Latest News

Caricamento notizie per IREN
stock quote shares IREN – IREN Ltd Stock Price stock today
news today IREN – IREN Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch IREN – IREN Ltd yahoo finance google finance
stock history IREN – IREN Ltd invest stock market
stock prices IREN premarket after hours
ticker IREN fair value insiders trading

IMRN – Immuron Limited ADR

IMRN — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

0.9

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

0.63

EPS This/Next Y

Price

0.81

Target Price

3.9

Analyst Recom

2

Performance Q

-8.62

Upside

-870.4%

Beta

0.82

Ticker: IMRN




15 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27IMRN0.77N/AN/A0
2026-03-03IMRN0.75N/AN/A0
2026-03-04IMRN0.7628N/AN/A0
2026-03-06IMRN0.88N/AN/A0
2026-03-09IMRN0.8403N/AN/A0
2026-03-10IMRN0.867N/AN/A0
2026-03-11IMRN0.8486N/AN/A0
2026-03-12IMRN0.86N/AN/A0
2026-03-13IMRN0.81N/AN/A0
2026-03-17IMRN0.75N/AN/A0
2026-03-18IMRN0.7249N/AN/A0
2026-03-20IMRN0.7118N/AN/A0
2026-03-25IMRN0.7705N/AN/A0
2026-03-26IMRN0.769N/AN/A0
2026-03-27IMRN0.81N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
15 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-02-27IMRN0.77- - -0.02
2026-03-02IMRN0.74- - -0.02
2026-03-03IMRN0.75- - -0.02
2026-03-04IMRN0.76- - -0.02
2026-03-05IMRN0.80- - -0.02
2026-03-06IMRN0.88- - -0.02
2026-03-09IMRN0.84- - -0.02
2026-03-10IMRN0.87- - -0.02
2026-03-11IMRN0.85- - -0.02
2026-03-12IMRN0.80- - -0.02
2026-03-13IMRN0.81- - -0.01
2026-03-17IMRN0.76- - -0.01
2026-03-18IMRN0.72- - -0.01
2026-03-19IMRN0.71- - -0.01
2026-03-20IMRN0.70- - -0.01
2026-03-23IMRN0.70- - -0.01
2026-03-24IMRN0.78- - -0.01
2026-03-25IMRN0.77- - -0.01
2026-03-26IMRN0.79- - -0.01
2026-03-27IMRN0.81- - -0.01
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-02-27IMRN027.600.50
2026-03-02IMRN028.060.50
2026-03-03IMRN028.060.50
2026-03-04IMRN028.060.50
2026-03-05IMRN028.060.50
2026-03-06IMRN028.060.50
2026-03-09IMRN02.000.50
2026-03-10IMRN02.000.50
2026-03-11IMRN02.000.82
2026-03-12IMRN02.000.82
2026-03-13IMRN02.000.82
2026-03-18IMRN01.730.82
2026-03-19IMRN01.730.82
2026-03-20IMRN01.730.82
2026-03-23IMRN01.770.82
2026-03-24IMRN01.770.82
2026-03-25IMRN01.770.90
2026-03-26IMRN01.770.90
2026-03-27IMRN01.770.90
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

1.77

Beta

0.82

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

46

Growth Score

46

Sentiment Score

90

Actual DrawDown %

87.3

Max Drawdown 5-Year %

-88.5

Target Price

3.9

P/E

Forward P/E

PEG

P/S

1.36

P/B

0.75

P/Free Cash Flow

EPS

-0.48

Average EPS Est. Cur. Y​

-0.01

EPS Next Y. (Est.)

-0.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-61.85

Relative Volume

0.33

Return on Equity vs Sector %

-62.9

Return on Equity vs Industry %

-46.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

IMRN Healthcare
$0.81
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
11/25
Volume
11/15
Valuation
12/20
TP/AR
1/10
Options
0/10
RSI
53
Range 1M
35.5%
Sup Dist
7.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
22 /100
WEAK
Momentum
0/25
Growth
17/30
Estimates
2/20
Inst/Vol
3/15
Options
0/10
EPS Yr
98.8%
EPS NY
-17.7%
52W%
5.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +381.5% upside
Quality
6/30
Valuation
16/30
Growth
10/25
Stability
7/10
LT Trend
1/5
Upside
+381.5%
Quality
46
Immuron Limited
Sector: Healthcare
Industry: Biotechnology
Employees: 7
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
IMRN

Latest News

Caricamento notizie per IMRN
stock quote shares IMRN – Immuron Limited ADR Stock Price stock today
news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch IMRN – Immuron Limited ADR yahoo finance google finance
stock history IMRN – Immuron Limited ADR invest stock market
stock prices IMRN premarket after hours
ticker IMRN fair value insiders trading

IMMP – Immutep Limited ADR

IMMP — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

3.57

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

EPS Last/This Y

0.17

EPS This/Next Y

Price

0.36

Target Price

3.79

Analyst Recom

2.71

Performance Q

-88.56

Upside

-3,800.0%

Beta

2.19

Ticker: IMMP




15 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27IMMP2.790.370.004386
2026-03-03IMMP2.630.360.024438
2026-03-04IMMP2.740.350.144515
2026-03-06IMMP2.760.350.004577
2026-03-09IMMP2.760.350.004577
2026-03-10IMMP2.760.350.004577
2026-03-11IMMP2.760.350.004577
2026-03-12IMMP2.760.350.004577
2026-03-13IMMP2.760.350.004577
2026-03-17IMMP0.40360.080.005169
2026-03-18IMMP0.410.080.005189
2026-03-20IMMP0.38690.080.005203
2026-03-25IMMP0.3720.080.005147
2026-03-26IMMP0.36460.080.005148
2026-03-27IMMP0.35620.080.005149
DateSymbolLatestP/C OIP/C VolTotal OI
15 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-02-27IMMP2.79- -64.3-0.26
2026-03-02IMMP2.68- -59.0-0.26
2026-03-03IMMP2.63- -56.6-0.26
2026-03-04IMMP2.74- -62.0-0.26
2026-03-05IMMP2.76- -62.9-0.26
2026-03-06IMMP2.76- -62.9-0.26
2026-03-09IMMP2.76- -65.5-0.26
2026-03-10IMMP2.76- -64.1-0.26
2026-03-11IMMP2.76- -64.1-0.26
2026-03-12IMMP2.76- -64.1-0.26
2026-03-13IMMP0.48- 49.8-0.26
2026-03-17IMMP0.40- 61.2-0.26
2026-03-18IMMP0.41- 60.8-0.26
2026-03-19IMMP0.42- 60.8-0.26
2026-03-20IMMP0.39- 61.9-0.13
2026-03-23IMMP0.38- 62.1-0.13
2026-03-24IMMP0.37- 62.3-0.13
2026-03-25IMMP0.37- 62.2-0.13
2026-03-26IMMP0.37- 62.3-0.13
2026-03-27IMMP0.36- 62.5-0.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-02-27IMMP0.0014.923.21
2026-03-02IMMP0.004.123.21
2026-03-03IMMP0.004.123.21
2026-03-04IMMP0.004.123.21
2026-03-05IMMP0.004.123.21
2026-03-06IMMP0.004.123.21
2026-03-09IMMP0.004.003.21
2026-03-10IMMP0.004.003.21
2026-03-11IMMP0.004.003.30
2026-03-12IMMP0.004.003.30
2026-03-13IMMP0.004.003.30
2026-03-18IMMP0.006.363.30
2026-03-19IMMP0.006.363.30
2026-03-20IMMP0.006.363.30
2026-03-23IMMP0.00117.203.30
2026-03-24IMMP0.00117.203.30
2026-03-25IMMP0.00117.203.57
2026-03-26IMMP0.00117.203.57
2026-03-27IMMP0.00117.203.57
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

117.2

Beta

2.19

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

25

Growth Score

27

Sentiment Score

16

Actual DrawDown %

93.5

Max Drawdown 5-Year %

-93.1

Target Price

3.79

P/E

Forward P/E

PEG

P/S

19.46

P/B

0.79

P/Free Cash Flow

EPS

-0.37

Average EPS Est. Cur. Y​

-0.13

EPS Next Y. (Est.)

-0.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2026.12

Relative Volume

0.33

Return on Equity vs Sector %

-112.2

Return on Equity vs Industry %

-95.9

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.13

EBIT Estimation

62.5
IMMP Healthcare
$0.35
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
0/20
Pullback
5/25
Volume
11/15
Valuation
12/20
TP/AR
0/10
Options
6/10
RSI
13.9
Range 1M
0.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
19 /100
WEAK
Momentum
0/25
Growth
6/30
Estimates
0/20
Inst/Vol
5/15
Options
8/10
EPS Yr
4.3%
EPS NY
22.2%
52W%
0.4%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +982.9% upside
Quality
5/30
Valuation
16/30
Growth
8/25
Stability
7/10
LT Trend
1/5
Upside
+982.9%
Quality
25
Immutep Limited
Sector: Healthcare
Industry: Biotechnology
Employees:
Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.
IMMP

Latest News

Caricamento notizie per IMMP
stock quote shares IMMP – Immutep Limited ADR Stock Price stock today
news today IMMP – Immutep Limited ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch IMMP – Immutep Limited ADR yahoo finance google finance
stock history IMMP – Immutep Limited ADR invest stock market
stock prices IMMP premarket after hours
ticker IMMP fair value insiders trading

GENE – Genetic Technologies Ltd. ADR

[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=GENE #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
GENE — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

0.76

Target Price

6.87

Analyst Recom

1

Performance Q

-14.99

Upside

N/A

Beta

1.11

Ticker: GENE




15 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27GENE0.765N/AN/A0
2026-03-03GENE0.765N/AN/A0
2026-03-04GENE0.765N/AN/A0
2026-03-06GENE0.765N/AN/A0
2026-03-09GENE0.765N/AN/A0
2026-03-10GENE0.765N/AN/A0
2026-03-11GENE0.765N/AN/A0
2026-03-12GENE0.765N/AN/A0
2026-03-13GENE0.765N/AN/A0
2026-03-17GENE0.765N/AN/A0
2026-03-18GENE0.765N/AN/A0
2026-03-20GENE0.765N/AN/A0
2026-03-25GENE0.765N/AN/A0
2026-03-26GENE0.765N/AN/A0
2026-03-27GENE0.765N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
15 items Current Page1 of 1




No data found




No data found

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=GENE 589 360 ]

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

1.11

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

30

Growth Score

29

Sentiment Score

7

Actual DrawDown %

98.5

Max Drawdown 5-Year %

-97.7

Target Price

6.87

P/E

Forward P/E

PEG

P/S

1.24

P/B

2.89

P/Free Cash Flow

EPS

-1.83

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-156.76

Relative Volume

Return on Equity vs Sector %

-680.2

Return on Equity vs Industry %

-667.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=GENE 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=GENE 589 450 ]
[News_GENE _Stock]
stock quote shares GENE – Genetic Technologies Ltd. ADR Stock Price stock today
news today GENE – Genetic Technologies Ltd. ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch GENE – Genetic Technologies Ltd. ADR yahoo finance google finance
stock history GENE – Genetic Technologies Ltd. ADR invest stock market
stock prices GENE premarket after hours
ticker GENE fair value insiders trading

WDS – Woodside Energy Group Ltd

WDS — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

0.2

Margin Of Safety %

Put/Call OI Ratio

0.17

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

24.79

Target Price

21.64

Analyst Recom

2.79

Performance Q

60.7

Upside

-25.5%

Beta

0.36

Ticker: WDS




15 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27WDS20.480.100.065555
2026-03-03WDS21.520.090.016586
2026-03-04WDS21.920.090.016776
2026-03-06WDS22.340.110.067482
2026-03-09WDS21.850.110.118245
2026-03-10WDS21.410.120.008947
2026-03-11WDS22.20.110.019037
2026-03-12WDS22.330.100.0111125
2026-03-13WDS22.330.100.0111125
2026-03-17WDS22.630.151.8411703
2026-03-18WDS22.850.180.0112028
2026-03-20WDS24.140.140.1915324
2026-03-25WDS23.670.150.6514990
2026-03-26WDS23.820.160.5815471
2026-03-27WDS24.780.170.0315648
DateSymbolLatestP/C OIP/C VolTotal OI
15 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-02-27WDS20.49- - -
2026-03-02WDS21.42- - -
2026-03-03WDS21.52- - -
2026-03-04WDS21.92- - -
2026-03-05WDS21.88- - -
2026-03-06WDS22.35- - -
2026-03-09WDS21.85- - -
2026-03-10WDS21.40- - -
2026-03-11WDS22.20- - -
2026-03-12WDS22.32- - -
2026-03-13WDS22.18- - -
2026-03-17WDS22.63- - -
2026-03-18WDS22.86- - -
2026-03-19WDS24.47- - -
2026-03-20WDS24.14- - -
2026-03-23WDS23.74- - -
2026-03-24WDS24.34- - -
2026-03-25WDS23.66- - -
2026-03-26WDS23.82- - -
2026-03-27WDS24.79- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-02-27WDS0-0.150.19
2026-03-02WDS00.050.19
2026-03-03WDS00.050.19
2026-03-04WDS00.050.19
2026-03-05WDS00.050.19
2026-03-06WDS00.050.19
2026-03-09WDS00.070.19
2026-03-10WDS00.070.19
2026-03-11WDS00.070.20
2026-03-12WDS00.070.20
2026-03-13WDS00.070.20
2026-03-17WDS00.410.20
2026-03-18WDS00.410.20
2026-03-19WDS00.410.20
2026-03-20WDS00.410.20
2026-03-23WDS00.440.20
2026-03-24WDS00.440.20
2026-03-25WDS00.440.20
2026-03-26WDS00.440.20
2026-03-27WDS00.440.20
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

0.44

Beta

0.36

Average Sales Estimate Current Quarter

2820

Average Sales Estimate Next Quarter

2432

Fair Value

Quality Score

81

Growth Score

56

Sentiment Score

88

Actual DrawDown %

8

Max Drawdown 5-Year %

-48.8

Target Price

21.64

P/E

17.43

Forward P/E

19.32

PEG

P/S

3.62

P/B

1.31

P/Free Cash Flow

EPS

1.42

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.97

Relative Volume

2.48

Return on Equity vs Sector %

-3.1

Return on Equity vs Industry %

-5.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

WDS Energy
$24.78
📉
Swing / Pullback
Buy the dip on strong trends
41 /100
WEAK
Trend
20/20
Pullback
6/25
Volume
3/15
Valuation
3/20
TP/AR
2/10
Options
7/10
RSI
72.1
Range 1M
86.6%
Sup Dist
4.5%
🚀
Momentum Growth
Ride accelerating trends
46 /100
WEAK
Momentum
20/25
Growth
1/30
Estimates
6/20
Inst/Vol
9/15
Options
10/10
EPS Yr
1.6%
EPS NY
-11.7%
52W%
96%
💎
Long-Term Value
Quality companies, undervalued
31 /100
WEAK
🟢 BUY +41.9% upside
Quality
9/30
Valuation
12/30
Growth
2/25
Stability
4/10
LT Trend
4/5
Upside
+41.9%
Quality
81
Woodside Energy Group Limited
Sector: Energy
Industry: Oil & Gas E&P
Employees: 4693
Woodside Energy Group Ltd engages in the exploration, evaluation, development, production, marketing, and sale of hydrocarbons in the Asia Pacific, Africa, the Americas, and the Europe. It produces liquefied natural gas, pipeline gas, crude oil and condensate, and natural gas liquids. The company holds interests in the Pluto LNG, North West Shelf, Wheatstone and Julimar-Brunello, Bass Strait, Ngujima-Yin FPSO, Okha FPSO, Pyrenees FPSO, Macedon, Shenzi, Mad dog, Greater Angostura, as well as Scarborough, Sangomar, Trion, Calypso, Browse, Liard, Ruby, Sangomar, Atlantis, Woodside Solar opportunity, and Sunrise and Troubadour. It is also involved in the development of new energy products and lower-carbon services. The company was formerly known as Woodside Petroleum Ltd and changed its name to Woodside Energy Group Ltd in May 2022. Woodside Energy Group Ltd was founded in 1954 and is headquartered in Perth, Australia.
WDS

Latest News

Caricamento notizie per WDS
stock quote shares WDS – Woodside Energy Group Ltd Stock Price stock today
news today WDS – Woodside Energy Group Ltd stock forecast ,stock prediction 2023 2024 2025
marketwatch WDS – Woodside Energy Group Ltd yahoo finance google finance
stock history WDS – Woodside Energy Group Ltd invest stock market
stock prices WDS premarket after hours
ticker WDS fair value insiders trading

 BHP – BHP Group Limited

BHP — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

0.64

Margin Of Safety %

7

Put/Call OI Ratio

0.67

EPS Next Q Diff

EPS Last/This Y

1.42

EPS This/Next Y

0.22

Price

69.52

Target Price

61.8

Analyst Recom

3.29

Performance Q

14.18

Upside

-24.6%

Beta

0.87

Ticker: BHP




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-02-27BHP81.50.691.38173630
2026-03-02BHP83.010.700.54174765
2026-03-03BHP78.320.712.07175695
2026-03-04BHP78.130.710.30176400
2026-03-05BHP75.620.700.01178725
2026-03-06BHP71.830.820.88164370
2026-03-09BHP72.940.830.24165769
2026-03-10BHP73.890.840.84165931
2026-03-11BHP73.360.831.71166440
2026-03-12BHP71.150.840.25167607
2026-03-13BHP70.770.840.24167607
2026-03-17BHP70.560.840.98169713
2026-03-18BHP68.310.840.25170541
2026-03-19BHP67.360.850.25169819
2026-03-20BHP65.230.800.65172078
2026-03-23BHP68.220.600.14140149
2026-03-24BHP68.770.633.48137655
2026-03-25BHP69.880.650.77139642
2026-03-26BHP68.50.654.82139953
2026-03-27BHP69.470.672.69141968
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-02-27BHP81.60- 3995.44.90
2026-03-02BHP83.04- 3067.24.97
2026-03-03BHP78.31- -802.94.97
2026-03-04BHP78.14- 1613.74.97
2026-03-05BHP75.60- 508.34.97
2026-03-06BHP71.84- 114.04.97
2026-03-09BHP72.94- 2531.04.98
2026-03-10BHP73.89- 1667.04.98
2026-03-11BHP73.35- 670.04.98
2026-03-12BHP70.78- -560.24.98
2026-03-13BHP68.74- -798.84.98
2026-03-17BHP70.50- 1416.44.98
2026-03-18BHP68.32- 277.94.98
2026-03-19BHP67.36- -304.64.98
2026-03-20BHP65.24- 10.64.98
2026-03-23BHP68.24- 1242.04.98
2026-03-24BHP68.77- 2995.34.98
2026-03-25BHP70.02- 2727.14.98
2026-03-26BHP68.50- 157.64.98
2026-03-27BHP69.52- 602.44.98
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-02-27BHP0-10.040.71
2026-03-02BHP0-9.970.71
2026-03-03BHP0-9.970.71
2026-03-04BHP0-9.970.71
2026-03-05BHP0-9.970.71
2026-03-06BHP0-9.970.71
2026-03-09BHP0-0.450.71
2026-03-10BHP0-0.450.71
2026-03-11BHP0-0.450.59
2026-03-12BHP0-0.450.59
2026-03-13BHP0-0.450.59
2026-03-17BHP0-0.390.59
2026-03-18BHP0-0.390.59
2026-03-19BHP0-0.390.59
2026-03-20BHP0-0.390.59
2026-03-23BHP0-0.350.59
2026-03-24BHP0-0.350.59
2026-03-25BHP0-0.350.64
2026-03-26BHP0-0.350.64
2026-03-27BHP0-0.350.64
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.35

Beta

0.87

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

74.5

Quality Score

81

Growth Score

55

Sentiment Score

81

Actual DrawDown %

16.5

Max Drawdown 5-Year %

-37.2

Target Price

61.8

P/E

17.24

Forward P/E

13.9

PEG

2.27

P/S

3.27

P/B

3.5

P/Free Cash Flow

17.12

EPS

4.03

Average EPS Est. Cur. Y​

4.98

EPS Next Y. (Est.)

5.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.97

Relative Volume

0.69

Return on Equity vs Sector %

5

Return on Equity vs Industry %

5.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.55

EBIT Estimation

602.4
BHP Basic Materials
$69.50
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
23/25
Volume
9/15
Valuation
12/20
TP/AR
2/10
Options
3/10
RSI
46
Range 1M
26.1%
Sup Dist
2%
🚀
Momentum Growth
Ride accelerating trends
N/A
29 /100
WEAK
Momentum
3/25
Growth
13/30
Estimates
6/20
Inst/Vol
3/15
Options
4/10
EPS Yr
28.4%
EPS NY
-2.7%
52W%
68.3%
💎
Long-Term Value
Quality companies, undervalued
38 /100
WEAK
🔴 SELL -1.4% upside
Quality
17/30
Valuation
3/30
Growth
11/25
Stability
4/10
LT Trend
3/5
Upside
-1.4%
Quality
81
MoS
7%
BHP Group Limited
Sector: Basic Materials
Industry: Other Industrial Metals & Mining
Employees: 39369
BHP Group Limited operates as a resources company in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and internationally. The company operates through Copper, Iron Ore, and Coal segments. It also engages in the mining of copper, uranium, gold, zinc, lead, molybdenum, silver, iron ore, cobalt, and metallurgical and energy coal. In addition, the company is involved in the mining, smelting, and refining of nickel, as well as potash development activities. Further, it provides towing, freight, marketing and trading, marketing support, finance, administrative, and other services. BHP Group Limited was founded in 1851 and is headquartered in Melbourne, Australia.
BHP

Latest News

Caricamento notizie per BHP
stock quote shares  BHP – BHP Group Limited Stock Price stock today
news today  BHP – BHP Group Limited stock forecast ,stock prediction 2023 2024 2025
marketwatch  BHP – BHP Group Limited yahoo finance google finance
stock history  BHP – BHP Group Limited invest stock market
stock prices BHP premarket after hours
ticker BHP fair value insiders trading
No more stocks to show